Category: PET Imaging

SNMMI Highlighting PET/MRI and Therapeutics in Two Unique Events

Therapeutics and PET/MRI are both areas of intense focus and innovation in nuclear medicine. The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is actively working to help members stay ahead of trends by holding two innovative conferences later this month that showcase these two topics. On October 25 –

Read More »

PET/CT Imaging New Tracer Guide

The landscape of PET/CT imaging is rapidly changing. Traditionally, physicians have used a sugar based radiopharmaceutical, 18Fluorodeoxyglucose or 18FDG, to perform the majority of PET/CT imaging. Over the past 20 years, this imaging agent was the only option available to many facilities across the United States. Recent breakthroughs in research, reimbursement,

Read More »
Making Healthcare Convenient. As Needed. When Needed. Where Needed.

©2020 Digirad Corporation. All rights reserved.